Each ml contains oxytetracycline 50 mg.
Buloxy 5% is a wide spectrum bacteriostatic antibiotic. It acts on gram-positive and gram-negative micro-organisms. It is particularly sensitive to streptococci, clostridia, E.coli, shigellae, brucellae, salmonellae, leptospirae etc. In addition, it is effective against some mycoplasmas, rickettsiae, chlamydiae, some protozoa andlarge viruses.
After administration of therapeutic dose of Fangtongoxy 5%, a high level of oxytetracycline in blood is achieved within half an hour to 4 hours.
Treatment of diseases caused by oxytetracycline-susceptible organisms in cattle, sheep and goats. Diseases including pneumonia and shipping fever complex associated with Pasteurella spp and haemophilus spp, infectious bovine kerato-conjunctivitis ( pinkeye ) caused by moraxella bovis, foot rot and diphtheria caused by fusobacterium necrophorum, bacterial enteritis ( scours) caused by escherichia coli, wooden tongue caused by actinobacillus lignierisii; leptospirosis caused by leptospira pomoma; wound infections and acute metritis caused by strains of staphylocci and streptococci organisms sensitive to oxytetracycline.
For cattle: Bronchopneumonia and other respiratory infections, infections of the gastrointestinal tract, metritis, mastitis, septicaemia, puerperal infections, secondary bacterrial infections primarily caused by viruses, etc.
For sheep and goats: Infections of respiratory, urogenital, gastrointestinal tract and hooves, mastitis, infected wounds,etc.
DOSAGE AND ADMINISTRATION:
Administer by intramuscular injection. The dose of the active principle oxytetracycline amounts to 10 mg/kg bodyweight of the animal. Administer for 3 – 5 days depending on the type and severity of the infection. The administration is carried out in the following volume:
Cattle 2ml / 10 kg bodyweight
Calves 2 ml / 10 kg bodyweight
Sheep and goats 2 ml / 10 kg bodyweight
Pigs 2 ml / 10 kg bodyweight
Buloxy 5% is not intended for cats, dogs and horses. It should not be given to animals in late pregnancy, animals with severe damages of liver and kidneys and to animals oversensitive to oxytetraycline.
SIDE – EFFECTS:
Sometimes a temporary swelling on the injection site occurs.
From last treatment, within 21 days for meat and edible tissues and within 7 days for milk.
A maximum of 20 ml may be injected at any one site for cattle, and 5 ml maximum for sheep and goats.
If total volume exceeds the above mentioned quantity, it should be divided and injected to more sites.
The drug must not be diluted.
In a cool dry place under 25℃, away from direct sunlight.
In a 100ml glass bottle.
The patented Dose-2-Weight Syringe® is the next generation liquid medication dispenser. Each Dose-2-Weight Syringe® is calibrated to the dosage strength of a specific medication and marked with multiple correlated measurements. These measurements may include, among others, weight or other patient characteristic, medication dosage or volume of the medication. This enhanced multi-indicia display increases the overall safety and accuracy of administration, by providing the ability to intuitively correlate the unit dosage to a specific patient characteristic.
Current dosing recommendations and monographs for OTC liquid medications commonly specify a set mL volume of medication for an age and weight range; rather than correlating an exact unit dosage, such as mg to the specific individual’s accurate age or weight. This dosing regimen results in younger and smaller mass patients receiving higher doses and older and larger mass patients receiving lower doses within the recommended dosing range.
The current age and weight dosing technique was established not only to support a more accurate weight based dosing, but also to offer a crucial alternative mode if the patient’s weight is not known. Despite the fact that this dosing model has been shown in a multitude of studies to be successful and now required in many monographs; unlike the Dose-2-Weight Syringe® none of the delivery devices incorporated within these medications are designed and display multi-mode dosing options.
The Dose-2-Weight Syringe® eliminates the need to correlate a volume, unit dosage or patient feature from a medication package or other media to the delivery device. These features circumvent the procedures shown to be the primary cause of error during the preparation and administration of OTC liquid medications.1
The Dose-2-Weight Syringe® enhances safety and convenience during preparation and administration while in parallel, providing ultra-precise dosing and visual reverification of the correct amount of medication for the specific patient
University of Missouri Health Care’s ENT and Allergy Center of Missouri introduces patients to the process of allergy testing. For more information about allergy testing or to schedule an appointment, please contact the ENT and Allergy Center of Missouri at (573) 882-5663.